Avalon Globocare Corp (ALBT) - News Archive

Avalon GloboCare: Innovating Health Monitoring with the KetoAir Breathalyzer and Expanding Affiliate Opportunities In a significant stride toward enhancing health monitoring solutions, Avalon GloboCare Corp. (NASDAQ: AL...

Avalon GloboCare Partners with SpecialtyHealth, Inc. to Enhance Police Chiefs Fitness Challenge with Innovative KetoAir Breathalyzer Technology In a pioneering initiative aimed at supporting law enforcement s health and...

Breaking News: YOOV Achieves 59.1% Annual Revenue Growth, Reporting Unaudited Revenue of $45.7 Million with Net Income of $3.4 Million for Calendar Year 2024In a remarkable turnaround, YOOV has announced unaudited finan...

Avalon GloboCare Corp. (NASDAQ: ALBT), a Freehold, New Jersey-based innovator in precision diagnostics and laboratory services, has received significant positive news from the Nasdaq Stock Market. On November 19, 2024,...

FREEHOLD, N.J. Avalon GloboCare Corp. (NASDAQ: ALBT), a leader in precision diagnostics and laboratory services, has officially rolled out its innovative BrAce for Impact affiliate marketing program to promote its lates...

Avalon GloboCare Implements 1-for-15 Reverse Stock Split to Regain Nasdaq ComplianceIn a strategic move aimed at bolstering its share price, Avalon GloboCare Corp. (NASDAQ: ALBT), an innovative player in precision diagn...

In a significant development for the medical technology sector, Avalon Laboratory Services, a subsidiary of Avalon Globocare Corp, is set to launch its proprietary FDA-registered external male catheter device. This prod...

Pioneering Health Innovations: Avalon GloboCare Launches Cutting-Edge DNA Testing Kit and KetoAir BreathalyzerIn a series of groundbreaking announcements, Avalon GloboCare Corp. (NASDAQ: ALBT), renowned for its innovati...

The Innovative Leap in Keto Management: Avalon GloboCare s Launch of KetoAir Breathalyzer in the U.S. The management of ketogenic diets has increasingly become a focal point for many health-conscious individuals and pra...

Summary: Avalon GloboCare Corp., a leading pioneer in cell-based technology, cellular therapy, and precision diagnostics, recently provided an update on the successful launch of their ground-breaking KetoAir breathalyze...

Avalon GloboCare Corp (NASDAQ: ALBT), a renowned developer of cell-based technology, cellular therapy, and precision diagnostics, has recently made an exciting announcement. The company revealed the official launch of i...

In a progressive move towards transforming the healthcare landscape, Avalon GloboCare Corp. (NASDAQ: ALBT), a trailblazing developer of innovative cell-based technology, cellular therapy, and precision diagnostics, has...

Avalon GloboCare Corp. (NASDAQ: ALBT), a prominent developer of innovative precision diagnostics and provider of clinical laboratory services, has recently enlisted the expertise of ChtrBx, a renowned marketing and bran...